AXIH .0145 and $EGYH .009 these 2 companies are EXTREMELY

New Post Public Reply Private Reply Replies (1) Message Board
AAAAMHIM HDOGTX #1
AXIH .0145 and $EGYH .009 these 2 companies are EXTREMELY OVERSOLD!

Let's start with AXIH

AXIH is at .0145 but 9 cents us only 40k shares, less than $1200 away? 52wkh .73! LOOK https://t.co/dpxXEg32Zz

AXIH closed down 40% yesterday and was down 47% today. Wait what's the 52 week high of AXIH? Oh yeah it was just 73 CENTS!!!...no biggie. When I alerted RXMD no one was talking about RXMD either. Ran to 8 cents 3 weeks later
It's what I do.

$AXIH Where are the environmentalists with their wallets?

Here we have a green technology that can make a huge and real difference. Where are the environmentalists and do gooders?...nowhere to be found. Quite a shame

The acceptance of this line of products is slowly gaining and the customer base is growing.
The pollution caused by plastic is becoming much more known by the masses and the fact that plastic is never going to compost or break down back into the earth is just plain scary.
The harm it is doing to the water and the earth is horrible. AXIH, on paper, looks like a dream investment given the push towards eco-friendly products. Add in the feature that their products also last longer than conventional options, and that looks like a sure-fire formula for success.

When positive ingredients don't add up to a delicious pie, ya gotta fire the baker and look for someone else to run the show.

Doesn't seem like the CEO has a vested interest in the company. Still, in his next job search, a failed AXIH ain't gonna look good on his resume.

Each day the pps drops another penny. You would think a biggie like Dow, Monsanto or Du Pont would be all over AXIH. All certainly have enough cookies in their cookie jars to make the technology a winner.

Would be a darn shame to watch this puppy die on the vine before it really even got started

I think the risk/reward quotient favors buying rather than selling. If AXIH continues to increase revenues, as they did through nine months in 2014, then the profits (EPS) will eventually come. At this level, I am a buyer, albeit one with fingers crossed. Reason I invest in this company is because they are an EXTREMELY OVERSOLD manufacturing firm with a new technology. Their railroad track is lighter, stronger, and easier to install. And lasts 3 to 5 times as long and is recyclable at the end of its working life. If you believe that they can find a new institutional investor then I would LOAD THE BOAT IMO.

$AXIH can run to 20 cents. Was at 19 cents just 2 months ago and 73 cents a YEAR AGO. People were jumping me on the bid today and have been accumulating heavy the last 3 days. UNKNOWN STOCK. http://www.nasdaq.com/symbol/axih/historical



$EGYH .009 DOWN 99% from last May EXTREMELY OVERSOLD. 1000%+ POTENTIAL. $300 million deal on the table, insiders soaked up 40 million shares, was trading at $1 last yr, news on the way. This is getting LOADED fellas, & is going to bounce like a man running on the moon. 9 page Update on their website, which most penny stocks would have put in a fluffy PR so that theycan DILUTE. Not here with EGYH, ONLY 100 MILLION A\S. YUMMY.

CEO last Monday predicts $5! Only 100 million A\SO with insiders holding 40 MILLION SHARES! WHY do they hold 40% of ALL shares? Traders hold over 41 million shares. Was at $1 last year.

http://www.energyhii.com

PEOPLE DON'T UNDERSTAND THE UNIQUE VALUE HERE. Why would insiders hold 40% of ALL shares 1 may ask...answer could be figured out from a 1st grader. The board is dead on IHUB and there is absolutely no buzz anywhere but that will change soon enough. CEO RELEASED A 9 PAGE UPDATE last Monday, it fell on deaf ears.

When I alerted RXMD at .0016 earlier in the year, the board was dead also it ran to 8 cents 3 weeks later. I alerted GEGU at .002 they laughed, it ran to 4 cents, alerted ERAO at .003 they laughed it ran almost 1000%, alerted $ALKM at .0036 it ran to 3 cents, alerted DTOR .0025 they laughed board dead, it ran 1000%+, alerted VGTL (not done yet) at .002 oh boy did I get HELL for that one, MONEYMADE BROUGHT 13 BASHERS who bashed 24 hours a day from .002-.035 (his whole crew lost BAD on it and he lost all his power and respect for being shady), alerted MGON .0009 it ran to .0086, alerted OMVS pre REVERSE SPLIT at .0013 ...post split would be less than 88 cents AND IT RAN TO $11! And many more. IT'S ALL there just look back at my past posts. The only one that may not be there is RXMD because I was banned from IHUB at the time. You will see RXMD at .002s but my twitter and Facebook friends got .0016. AND SO MANY MORE THIS YEAR ALONE.

I can even take it back to 2011 when I alerted DEGH at .0025 but was ignored for weeks till it ran over 40,000% to $1.35 in 6 months. ALL THE CLUES WERE THERE AND FELL ON DEAF EARS AS I TRIED AND TRIED to get the word out. But I'm FAR FROM A GENIUS. I trade MATHEMATICALLY. CLUES WILL BE IN PLAIN SIGHT AND IGNORED.

EGYH HAS 100 MILLION A\S AND A MEATY 9 PAGE UPDATE. PAGE 7 WAS WHERE THE SUPER ORGANIC MEAT IS.....yet ignored. They'll learn soon.

100 million A\S insiders holding 40 million shares? Sub 1 cent? Not only is EGYH not bloated. IT HAS THE SMALLEST float vs price of 10,000 stocks in the OTC. there is not one with a smaller float vs price that is not a shell. I challenge any I ever to find one and I'll buy it RIGHT NOW
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OMLYCLO Shakes Up U.S. Biologic Market as Key Player

Updated Category News Views 14

Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...

Continue Reading
Aging at Home: The Real Costs and Obstacles Ahead

Updated Category News Views 11

Facing the Realities of Aging In Place Alright, let's talk straight. Everyone dreams of staying home in their twilight years, kicking back in their favorite chair with family nearby. But the harsh truth? That comfort comes with a price tag. According to Northwestern Mutual's 2026 Planning & Progress Study, up to 83% of Boomers+ and most other generations fancy the idea of...

Continue Reading
GL1F Crypto: A Breakthrough in On-Chain AI for Crypto

Updated Category News Views 9

The Dawn of On-Chain Machine Learning In a world where crypto folks often tout decentralization like it’s the holy grail, GenesisL1 is throwing open the doors to a new kind of crypto playground with GL1F Crypto. A decentralized on-chain AI studio? Sounds like sci-fi, but here we are—hands on the precipice of democratized machine learning in your browser. A Lab in...

Continue Reading
Indiana American Water's PFAS Credits Total $25.5M

Updated Category News Views 7

Indiana American Water Dishes Out Big Buck Refunds Swing by Indiana American Water's latest move, and what do you see? A whopping $25.5 million in PFAS settlement credits being doled out to customers. That's right, this ain't your everyday water utility story—there's real money on the line here. Over four rounds of bill credits since November 2025, customers have seen...

Continue Reading
#L.A. Rising Podcast: From Fires to International Fame

Updated Category News Views 15

From Ashes to Airwaves Gritty stories of survival often cut deeper than any wonky industry analysis or corporate earnings report. When you've been through the wringer and come out the other side, that experience sticks with you—and for Kim S. Marshall, it ignited something personal yet universal with the #L.A. Rising podcast. Emerging from the 2025 L.A. fires, this...

Continue Reading
Event Industry Power 50 Voting Surge Ahead of Close

Updated Category News Views 14

An Unexpected Wave of Enthusiasm in Event Industry The Event Industry Power 50 is getting some serious action this year. Over 3,500 votes have already rolled in, smashing last year's numbers with days still left on the clock. It seems like folks can't wait to see their favorite event powerhouses crowned at this year's gala, which kicks off October 27 in New York City....

Continue Reading
Travelers Turn to Direct Booking Amid Cost Surge

Updated Category News Views 18

Getting Ahead of the Travel Expense Game Rising fees and tighter budgets haven't persuaded holiday travelers to abandon their plans. Instead, they’re sharpening their axes, looking for clearer paths to their vacation goals without slicing off an arm and a leg. With the cost of travel climbing faster than a runaway elevator, folks are getting smart about where their...

Continue Reading
Hiromi Asai's Akatsuki Shines at Paris Fashion Week

Updated Category News Views 12

An Ode to Tradition Amid Modern Menswear From the bustling avenues of New York to the storied streets of Paris, Hiromi Asai is showcasing something that strikes a chord deep in the fashion industry's soul. Her Spring/Summer 2027 collection, "Akatsuki — Before the Dawn," takes its rare blend of age-old Japanese textile craftsmanship across the pond to the City of Light....

Continue Reading
Palm Beach Royals Boost Pickleball's Popularity Surge

Updated Category News Views 21

A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...

Continue Reading
TRIMAX Poised to Meet AI-Driven Power Challenges

Updated Category News Views 12

TRIMAX's Bold Move into AI-Powered Infrastructure It feels like we're standing on the cusp of a seismic shift, folks. Artificial intelligence isn't just another buzzword anymore—it's a juggernaut reshaping our digital world. TRIMAX Power Systems is gearing up to ride this wave, with its eyes set on capturing a chunk of the booming demand for fast-deployable power...

Continue Reading

Top 5 Most Recently Viewed Articles

Armstrong Company Sees Leadership Shake-Up for Growth

Updated Category News Views 254

New Leadership at The Armstrong Company It’s about time. Armstrong’s rolling out fresh faces in the top spots. Todd Watson’s stepping down as CEO, but don’t get it twisted—he’s not leaving the building; he’s now co-chair along with his cousin Mark Pickens. These guys are the latest entries in a long line of leadership dating back to their founders in 1957....

Continue Reading
NVIDIA Prepares for Q3 Financial Results Conference

Updated Category News Views 194

NVIDIA's Upcoming Conference Call for Financial Results NVIDIA is gearing up to connect with stakeholders through a conference call planned for a future date. This call will focus on discussing the financial results for the company's third quarter of the current fiscal year. Investors and analysts will have the opportunity to gain insights into the financial landscape of...

Continue Reading
Free Heart and Kidney Health Screenings Set for January in Seattle

Updated Category News Views 268

Free Heart and Kidney Health Screenings in Seattle Residents of Seattle have a valuable opportunity coming up with the Heart & Kidney Health Screening initiative offered by Care Access. This program aims to enhance awareness of crucial health risk factors, particularly the dangerous lipoprotein(a), often abbreviated as Lp(a). Affecting one in five individuals, high Lp(a)...

Continue Reading
Important Legal Notification for Replimune Group Investors

Updated Category News Views 170

Protect Your Investment with Legal Guidance In the fast-paced world of investing, timely information is crucial for making informed decisions. This is especially true for investors in Replimune Group, Inc. (NASDAQ: REPL) who have participated in transactions within recent class periods. Understanding your rights and options can significantly affect your financial future....

Continue Reading
Class Action Alert: Kyverna Therapeutics Investors Take Note

Updated Category News Views 110

Important Opportunity for Kyverna Therapeutics, Inc. Investors Kyverna Therapeutics, Inc. (NASDAQ: KYTX) provides a significant opportunity for its shareholders due to a potential class action lawsuit concerning possible securities fraud. If you're someone who purchased common stock during the company’s initial public offering (IPO), you might be entitled to...

Continue Reading